Valuation: DIAGNOS Inc.

Market Cap 27.69M 19.62M 17.23M 15.95M 14.68M 1.89B 28.06M 190M 74.35M 926M 73.71M 72.11M 3.2B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 27.17M 19.25M 16.9M 15.65M 14.4M 1.85B 27.52M 187M 72.94M 909M 72.32M 70.74M 3.14B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
95.78%
Yield 2025 *
-
Yield 2026 -
1 week-13.21%
Current month-8.00%
1 month-1.08%
3 months-8.00%
6 months-26.98%
Current year-38.67%
1 week 0.22
Extreme 0.225
0.26
1 month 0.22
Extreme 0.215
0.28
Current year 0.18
Extreme 0.175
0.38
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.6
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2008-04-30
Chief Operating Officer - 2024-01-15
Director TitleAgeSince
Director/Board Member - 2000-09-20
Director/Board Member 72 2020-09-27
Chairman 69 2025-10-29
Date Insider Type Main position Quantity % Market Cap.
6/11/26 Option

Chief Executive Officer

300,000 0.2491%
6/11/26 Option

Chief Operating Officer

200,000 0.1661%
6/11/26 Option

Chairman

300,000 0.2491%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-13.21%+4.55%-52.58% 19.7M
-1.17%-27.47%-26.37%+52.12% 200B
-0.95%+1.15%+25.28%+54.10% 95.09B
-2.67%+1.69%-50.13%-54.92% 88.57B
-1.33%+1.82%-30.37%-35.87% 84.46B
-2.54%-0.97%-37.97%-4.85% 59.15B
-1.25%-2.64%-32.32%-25.94% 45.64B
+1.22%+1.57%+9.33%+224.00% 35.53B
+0.33%+0.03%+2.32%+82.82% 35.2B
+1.49%+1.50%-19.97%+7.24% 34.27B
Average -0.54%-3.08%-15.56%+24.61% 67.81B
Weighted average by Cap. -0.71%-6.58%-20.46%+25.56%

Financials

2025 2026
Net sales 104K 73.53K 64.56K 59.8K 55.01K 7.08M 105K 713K 279K 3.47M 276K 270K 12.01M 65.48K 46.38K 40.73K 37.72K 34.7K 4.47M 66.33K 450K 176K 2.19M 174K 170K 7.57M
Net income -4.29M -3.04M -2.67M -2.47M -2.27M -292M -4.34M -29.46M -11.51M -143M -11.41M -11.16M -496M -4.56M -3.23M -2.83M -2.62M -2.41M -311M -4.61M -31.31M -12.23M -152M -12.12M -11.86M -527M
Net Debt -164K -116K -102K -94.31K -86.77K -11.17M -166K -1.13M -439K -5.47M -436K -426K -18.93M -525K -372K -327K -303K -278K -35.83M -532K -3.61M -1.41M -17.56M -1.4M -1.37M -60.74M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
26-07-21 CA$0.2300 0.00% 117,500
26-07-20 CA$0.2300 +2.22% 142,440
26-07-17 CA$0.2250 -2.17% 107,021
26-07-16 CA$0.2300 -11.54% 353,433
26-07-15 CA$0.2600 0.00% 252,300

Annual profits - Rate of surprise